Regulator seeking action on medicines shortages
by Gary Finnegan: The European Medicines Agency (EMA) is coordinating a collective response to the medicines shortages which have plagued several European countries in recent years.
by Gary Finnegan: The European Medicines Agency (EMA) is coordinating a collective response to the medicines shortages which have plagued several European countries in recent years.
by Gary Finnegan: The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of seven new medicines, including one advanced therapy medicinal product (ATMP), at… read more.
Silvio Danese, Humanitas Clinical and Research Hospital, Milan, Italy. Article by Maria Dalby – The current paradigm for managing inflammatory conditions is to suppress the inflammatory response by… read more.
by Bruce Sylvester: Smoking cessation treatment with varenicline and bupropion does increase serious neuropsychiatric side effects, researchers reported in The Lancet on April 22, 2016.
by Bruce Sylvester: Treatment with clemastine fumarate, an over-the-counter antihistamine used for allergies and the common cold, has partially reversed damage to the visual system in people with… read more.
by Bruce Sylvester: Hyrdomorphone, a licensed pain medication, shows efficacy in treating chronic heroin addiction, researchers from the SALOME (the Study to Assess Longer-term Opioid Medication Effectiveness) trial… read more.
by Gary Finnegan: Six new medicines, two of which had been fast-tracked, were given positive reviews from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)…. read more.
by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.
by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.
by Thomas R. Collins: Standing at the center of a decade and a half of stunning advancements in the treatment of multiple myeloma is the ubiquitin proteasome pathway… read more.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s Committee for Medicinal… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.